RNAC · CIK 0001453687 · operating
Cartesian Therapeutics, Inc. (RNAC) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $205 million, Cartesian Therapeutics, Inc. is a micro-cap company. The stock currently trades at $7.51, down 1.05% today, with a 52-week range of $5.98–$18.97.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-4.49 | $-4.48 | -170.5% | |
| 2023 | $-1.66 | $-1.66 | -1760.0% | |
| 2022 | $0.10 | $0.24 | +145.5% | |
| 2021 | $-0.22 | $-0.22 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2016 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-13 | 0001453687-25-000060 | SEC ↗ |
| 2023-12-31 | 2024-03-07 | 0001453687-24-000036 | SEC ↗ |
| 2022-12-31 | 2023-03-02 | 0001453687-23-000040 | SEC ↗ |
| 2021-12-31 | 2022-03-10 | 0001453687-22-000051 | SEC ↗ |
| 2020-12-31 | 2021-03-12 | 0001453687-21-000031 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001453687-20-000028 | SEC ↗ |
| 2018-12-31 | 2019-03-15 | 0001453687-19-000032 | SEC ↗ |
| 2017-12-31 | 2018-03-15 | 0001453687-18-000012 | SEC ↗ |
| 2016-12-31 | 2017-03-28 | 0001453687-17-000014 | SEC ↗ |